Comparison of efficacy of intralesional Injection Vitamin D3 with intralesional MMR vaccine in the management of cutaneous warts
Phase 3
- Conditions
- Health Condition 1: B079- Viral wart, unspecified
- Registration Number
- CTRI/2023/05/053231
- Lead Sponsor
- INHS Asvini dermatology dept
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All diagnosed immunocompetent cases (clinically and dermoscopically) of cutaneous warts (aged 5-70 yrs) attending Dermatology OPD in a tertiary care hospital in Mumbai.
Exclusion Criteria
Patients with keloidal tendencies.
(2) Patients with prior allergic response to MMR or vitamin D3.
(3)Patients with autoimmune conditions.
(4) Patients with infected warts
(5) Patients with genital warts.
(6) Pregnant /lactating females.
(7) Known case of HIV/HBsAg/HCV
(8)Immunosuppressed patients.
(9) Consent Denial, uncooperative patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method